Characterization of V3 Sequence Heterogeneity in Subtype C Human Immunodeficiency Virus Type 1 Isolates from Malawi: Underrepresentation of X4 Variants
- Li-Hua Ping1,2,
- Julie A. E. Nelson1,
- Irving F. Hoffman1,2,
- Jody Schock1,3,
- Suzanna L. Lamers4,
- Melissa Goodman1,2,
- Pietro Vernazza5,
- Peter Kazembe6,
- Martin Maida6,
- Dick Zimba6,
- Maureen M. Goodenow4,
- Joseph J. Eron Jr.1,2,
- Susan A. Fiscus1,3,
- Myron S. Cohen1,2, and
- Ronald Swanstrom1,7,*
- UNC Center For AIDS Research,1
- Department of Medicine,2
- Department of Microbiology and Immunology,3 and
- Department of Biochemistry and Biophysics,7 University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;
- Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine, Gainesville, Florida4;
- Institute for Clinical Microbiology and Immunology, St. Gallen, Switzerland5; and
- Lilongwe Central Hospital, Lilongwe, Malawi6
ABSTRACT
We have examined the nature of V3 sequence variability among subtype C human immunodeficiency virus type 1 (HIV-1) sequences from plasma-derived viral RNA present in infected men from Malawi. Sequence variability was assessed by direct sequence analysis of the V3 reverse transcription-PCR products, examination of virus populations by a subtype C V3-specific heteroduplex tracking assay (V3-HTA), and selected sequence analysis of molecular clones derived from the PCR products. Sequence variability in V3 among the subtype C viruses was not associated with the presence of basic amino acid substitutions. This observation is in contrast to that for subtype B HIV-1, where sequence variability is associated with such substitutions, and these substitutions are determinants of altered coreceptor usage. Evolutionary variants in subtype C V3 sequences, as defined by the V3-HTA, were not correlated with the CD4 level in the infected person, while such a correlation was found with subtype B V3 sequences. Viruses were isolated from a subset of the subjects; all isolates used CCR5 and not CXCR4 as a coreceptor, and none was able to grow in MT-2 cells, a hallmark of the syncytium-inducing phenotype that is correlated with CXCR4 usage. The overall sequence variability of the subtype C V3 region was no greater than that of the conserved regions of gp120. This limited sequence variability was also a feature of subtype B V3 sequences that do not carry the basic amino acid substitutions associated with altered coreceptor usage. Our results indicate that altered coreceptor usage is rare in subtype C HIV-1 isolates in sub-Saharan Africa and that sequence variability is not a feature of the V3 region of env in the absence of altered coreceptor usage.
FOOTNOTES
- Received 19 February 1999.
- Accepted 20 April 1999.
-
↵* Corresponding author. Mailing address: CB7295, Rm 22-006 Lineberger Bldg., University of North Carolina at Chapel Hill, Chapel Hill, NC 27599. Phone: (919) 966-5710. Fax: (919) 966-8212. E-mail: risunc{at}med.unc.edu.
- Copyright © 1999 American Society for Microbiology











